Leading Provider of Workers' Comp Pharmacy & Ancillary Benefits Management Programs

NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance :: 5/20/13

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall 

Spring 2013 RxInformer Now Available as iPad App :: 5/16/13

Spring 2013 Issue of RxInformer Journal Provides Workers’ Comp Professionals with Guidance on Emerging Trends

FDA approves label changes for zolpidem products :: 5/14/13

New dosing and a recommendation to avoid driving the day after Ambien CR use

FDA Statement: Original Opana ER Relisting Determination :: 5/10/13

Opana ER  Extended-Release Tablets was not withdrawn for safety or effectiveness

XYMOGEN identifies allergen oversight by third-party manufacturer :: 5/9/13

Nutraceutical company XYMOGEN in Orlando, Fla., is recalling artriphen

FDA Alert: Lack of Sterility Assurance of Drug Products :: 5/9/13

Practices at The Compounding Shop in FL raise concerns about sterility assurance 

Heathesystems' CMO Comments on Rx Drug Abuse :: 5/2/13

Heathesystems' CMO Dr. Robert Goldberg puts the problem of Rx drug abuse into perspective

Healthesystems Weighs in on the FDA’s Ban on Generic OxyContin :: 5/2/13

Kate O’Lenic & Todd Pisciotti, Quoted in Risk & Insurance Magazine

Fraudulent Versions of Botox Found in the US :: 4/29/13

Versions of Botox that are not approved by the FDA are being sold to medical practices. 

Healthesystems Named a Tampa Bay Top 100 Workplace :: 4/26/13

Top 100 Workplaces by the Tampa Bay Times

Nora Apothecary & Alternative Therapies Announces a Voluntary Multi-State Recall :: 4/23/13

Nora Apothecary & Alternative Therapies recall of all sterile drug products 

Balanced Solutions Compounding Pharmacy- Voluntary Nationwide Recall :: 4/22/13

 FDA announces nationwide recall by Balanced Solutions Compounding Pharmacy 

GlaxoSmithKline Experiencing a Backorder Situation for Horizant :: 4/18/13

FDA Approves Abuse-Deterrent Labeling for Reformulated OxyContin :: 4/17/13

Agency will not approve generics to original OxyContin

ApothéCure, Inc. Announces Voluntary Recall :: 4/16/13

Voluntary Nationwide Recall of All Lots of All Sterile Products 

FDA Alert - 2013 Pharmacy Inspections :: 4/16/13

Results of compounding pharmacies inspections 

FDA BeSafeRx :: 4/15/13

Campaign to raise awareness of the dangers of medicines from fake online pharmacies

Healthesystems Launches e-Tool :: 4/11/13

e-Tool to Help Workers’ Compensation Carriers and Payers Manage Opioid Use by Injured Workers 

Pallimed Solutions, Inc. Announces Voluntary Recall :: 3/27/13

Recall of All Sterile Compounded Products Dispensed Since January  2013 

Voluntary Nationwide Recall Of All Lots Of All Compounded Products :: 3/25/13

Recall Compounded Products Due To Potential Mold Contamination

Recall - All Sterile Products Recalled Due To Lack of Sterility Assurance :: 3/25/13

 Clinical Specialties is voluntarily recalling all lots of all sterile products 

Healthesystems Appoints Dr. Robert L. Goldberg as Chief Medical Officer :: 3/21/13

Healthesystems Expands Clinical Services Excellence

Kate O'Lenic, Healthesystems Clinician, Quoted in Risk & Insurance Magazine :: 3/20/13

 "Ushering in a New Class of Painkillers"

WA New Opioid Treatment Guidelines :: 3/18/13

State Department has adopted new opioid treatment guidelines

6 Tip-offs to Rip-offs: Don't Fall for Health Fraud Scams :: 3/14/13

FDA offers some tip-offs to help you identify rip-offs

FDA Investigating Reports From Incretin Mimetic Drugs for Type 2 Diabetes :: 3/14/13

Possible Increased Risk of Pancreatitis and Pre-Cancerous Pancreas Findings 

Azithromycin and the Risk of Potentially Fatal Heart Rhythms :: 3/13/13

Azithromycin can cause abnormal changes in the electrical activity of the heart

Proposed Model Act :: 3/12/13

Proposed Model Act on Workers’ Compensation Repackaged Pharmaceutical Reimbursement Rates

NY Moves Hydrocodone to Schedule II :: 3/4/13

Hydrocodone moved from Schedule III to Schedule II

Healthesystems Publishes New Report :: 2/21/13

 Savings of up to 80% on Repackaged Drugs

Voluntarily Recalling all lots of Reumofan Plus Tablets :: 2/20/13

 Recalling all lots of Tablets Due to Undeclared Drug Ingredients

Mass Dept of Public Health Announces Update on Pharmacy Inspections :: 2/6/13

 Governor’s budget provides resources for pharmacy inspections and oversight

WA New Penalty Assessment :: 2/5/13

Amended medical bill late payment requirements

Oregon Developing Medical State Reporting and Electronic Billing Rules :: 1/30/13

Oregon Workers’ Compensation Division to adopt a new set of rules 

Virginia Legislature Contemplates Workers’ Comp Fee Schedule :: 1/30/13

Idaho Legislature Approves Pharmacy Fee Schedule :: 1/30/13

new fee schedule will become effective on July 1, 2013

Healthesystems is Again Awarded URAC Accreditation :: 1/18/13

 Healthesystems continues its accreditation standing 

FDA Opana Warning :: 1/14/13

FDA warns about serious blood disorder resulting from misuse of Opana ER

FDA Alert: Risk of next-morning impairment after use of insomnia drugs :: 1/10/13

FDA requires lower recommended doses for drugs containing zolpidem 

New Mexico adopted amendments and new provisions :: 1/10/13

 The New Mexico WCA adopted amendments to rule parts 3, 4 and 7

NYWCB Adopts Pharmacy & DME Fee Schedules :: 1/3/13

NYWCB has adopted permanent pharmacy and DME fee schedule rules

Victory Pharma Inc. Pays to Resolve Kickback Allegations :: 12/31/12

Pays to Resolve Kickback Allegations in Connection with Promotion of Its Drugs

Three Lots of Hydrocodone Bitartrate and Acetaminophen Tablets Recalled :: 12/21/12

 Recall Impacts Three Lots of Hydrocodone Bitartrate and Acetaminophen Tablets

Pradaxa should not be used in patients with mechanical prosthetic heart valves :: 12/20/12

Pradaxa should not be used to prevent stroke or blood clots in patients 

Dietary Supplement Reumofan Plus relabeled and sold as “WOW” :: 12/20/12

Reumofan Plus is being relabeled and sold under the name “WOW"

Combination treatment:Incivek (telaprevir), peginterferon alfa, and ribavirin :: 12/19/12

Serious skin reactions after combination treatment 

Chantix- Updated Safety Review On The Risk of Cardiovascular Adverse Events :: 12/12/12

FDA is informing the public about the results of a large, combined analysis

Hydrocodone Bitartrate and Acetaminophen Tablet Recall :: 12/10/12

Recall of 101 Lots of Hydrocodone Bitartrate and Acetaminophen Tablets

New York Pharmacy, DME Fee Schedule Becomes Effective :: 12/6/12

DME Fee Schedule Becomes Effective

California Creates FAQ Website for Workers’ Comp Reform Bill :: 12/6/12

 CA DWC has created a FAQ webpage